ArticleEvidence-based medicine2015

Long-term ticagrelor therapy in patients with prior myocardial infarction significantly reduces ischaemic events, albeit with increased bleeding.

Dimitrios AlexopoulosPubMed ↗Publisher ↗

No numbers read from the abstract.